PubAg

Main content area

Process of immunogenic cell death caused by disulfiram as the anti-colorectal cancer candidate

Author:
You, Si-yuan, Rui, Wen, Chen, Shuai-tong, Chen, Hong-ce, Liu, Xia-wan, Huang, Jun, Chen, Hong-yuan
Source:
Biochemical and biophysical research communications 2019 v.513 no.4 pp. 891-897
ISSN:
0006-291X
Subject:
alcohol abuse, antineoplastic activity, antineoplastic agents, apoptosis, calreticulin, colorectal neoplasms, copper, death, disulfiram, dose response, drug therapy, flow cytometry, heat shock proteins, immune response, mice, neoplasm cells, tissues, toxicity
Abstract:
Disulfiram (DSF), a drug widely used to control alcoholism, which has anticancer activity by inducing apoptosis in a copper (Cu)-dependent manner. Numerous evidences from mouse experiments indicated that some anti-cancer agents of chemotherapeutic drugs favor the induction of immunogenic cancer cell death (ICD) leading to tumor-specific immune responses. However, whether DSF could induce the colorectal tumor cells death and the mechanism involved in ICD regulatory remains elusive. The main objective of this study was to elucidate the effect of DSF/Cu on the apoptosis of colorectal cancer (CRC) cells and the expression of the two major ICD markers in CRC cells: calreticulin (CRT) and heat shock proteins (HSP) 70.Firstly, the toxicity of DSF/Cu in HCT116, SW620 and HCT8 cells was assayed by MTT. Flow cytometry was utilized to detect the apoptosis effects. The effects of DSF/Cu on the expression of ICD-related molecules in tumor tissues were further verified in the CRC xenograft mouse model.The results showed that DSF/Cu increase apoptosis of these three cells in a dose dependent manner and significantly inhibited the proliferation at the concentration range from 0.05 to 1.6 μM. Furthermore, the expression of CRT and HSP70 on the cell surface also increased. The rate of transplanted tumors grew slowly, and the expression of CRT and HSP70 in colorectal cancer tissues was increased after treated with DSF/Cu.In conclusion, our results show that DSF/Cu exerts anti-colorectal cancer and its underlying mechanisms are associated with the enhancement of molecules expression of cell ICD. These results provide experimental evidence and theory basis of therapy for developing the DSF/Cu as the drug for CRC.
Agid:
6373835